LGND Related Trader Talk
-
Ligand Pharmaceuticals (LGND), GSK's (GSK) promacta approved - Report
-
UPDATE: Onyx Pharmaceuticals (ONXX) Kyprolis approved
-
Ligand Pharma (LGND) Shares Add 4+% After Hours as FDA Panel Votes In Favor of Onyx's (ONXX) Carfilzomib
-
Loeb's Third Point Q4 13F Breakdown: Ups Bets In Financials, Exits Large Pharma
-
Loeb's Third Point Buys Into Starwood (HOT) and Tibco (TIBX), Dumps Yahoo! (YHOO)
-
Summary of Loeb's Third Point LLC 13F
-
11 Stocks Added to NASDAQ Biotechnology Index
-
13D from Dan Loeb Filed on LGND Urging to Sell Company; Says Worth $14/Sh
Back to LGND Stock Lookup
